Zhou F, Shen C, Hsu YH, et al. DNA methylation-based subclassification of psoriasis in the Chinese Han population. Front Med. 2018;12(6):717-725. doi:10.1007/s11684-017-0588-6
Agostini M, Schoenmakers E, Beig J, et al. A Pharmacogenetic Approach to the Treatment of Patients With Mutations. Diabetes. 2018;67(6):1086-1092. doi:10.2337/db17-1236
Shantha JG, Mattia JG, Goba A, et al. Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: Reverse Transcription-Polymerase Chain Reaction and Cataract Surgery Outcomes of Ebola Survivors in Sierra Leone. EBioMedicine. 2018;30:217-224. doi:10.1016/j.ebiom.2018.03.020
Shafee R, Nanda P, Padmanabhan JL, et al. Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls. Transl Psychiatry. 2018;8(1):78. doi:10.1038/s41398-018-0124-8
Hayden MA, Ordulu Z, Gallagher S, et al. Clinical, pathologic, cytogenetic, and molecular profiling in self-identified black women with uterine leiomyomata. Cancer Genet. 2018;222-223:1-8. doi:10.1016/j.cancergen.2018.01.001
Giese AK, Rost NS. In search of a putative imaging biomarker for Fabry disease: Go with the flow? Neurology. 2018;90(16):721-722. doi:10.1212/WNL.0000000000005320
Guissart C, Latypova X, Rollier P, et al. Dual Molecular Effects of Dominant RORA Mutations Cause Two Variants of Syndromic Intellectual Disability with Either Autism or Cerebellar Ataxia. Am J Hum Genet. 2018;102(5):744-759. doi:10.1016/j.ajhg.2018.02.021
Moran CJ, Huang H, Rivas M, Kaplan JL, Daly MJ, Winter HS. Genetic variants in cellular transport do not affect mesalamine response in ulcerative colitis. PLoS One. 2018;13(3):e0192806. doi:10.1371/journal.pone.0192806
Frayling TM, Beaumont RN, Jones SE, et al. A Common Allele in FGF21 Associated with Sugar Intake Is Associated with Body Shape, Lower Total Body-Fat Percentage, and Higher Blood Pressure. Cell Rep. 2018;23(2):327-336. doi:10.1016/j.celrep.2018.03.070
Thorsson V, Gibbs DL, Brown SD, et al. The Immune Landscape of Cancer. Immunity. 2018;48(4):812-830.e14. doi:10.1016/j.immuni.2018.03.023